Location History:
- Amsterdam, NL (2018)
- Blokker, NL (2022 - 2023)
Company Filing History:
3 out of 27 
1 out of 1 Years Active: 2018-2023
Title: Maria Clara Brouwer: Innovator in Antibody Research
Introduction
Maria Clara Brouwer is a prominent inventor based in Blokker, Netherlands. She has made significant contributions to the field of antibody research, particularly in the development of therapies targeting complement activation disorders. With a total of 3 patents to her name, Brouwer's work is paving the way for innovative treatments.
Latest Patents
Brouwer's latest patents include groundbreaking inventions related to Factor H potentiating antibodies. These patents describe novel isolated, synthetic, or recombinant antibodies and fragments that are specific for Factor H. The inventions also detail the use of these antibodies, fragments, nucleic acids, or vectors for inhibiting complement activation and treating disorders associated with this activation. Her work is crucial in advancing therapeutic options for patients suffering from complement-related diseases.
Career Highlights
Throughout her career, Maria Clara Brouwer has worked with notable organizations, including Stichting Sanquin Bloedvoorziening and Gemini Therapeutics Sub, Inc. Her experience in these institutions has allowed her to refine her expertise in antibody development and therapeutic applications.
Collaborations
Brouwer has collaborated with esteemed colleagues such as Taco Willem Kuijpers and Diana Wouters. These partnerships have further enhanced her research and contributed to the success of her innovative projects.
Conclusion
Maria Clara Brouwer is a trailblazer in the field of antibody research, with a focus on complement activation disorders. Her patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.